Astellas Pharma Inc. Newsletter
-
New FDA-approved drug combo reduces prostate cancer death risk by 40 percent
22 Oct 2025 06:11 GMT
… combination of two FDA-approved drugs, enzalutamide and leuprolide, significantly improves … was funded by Pfizer and Astellas Pharma, enrolled over 1,000 patients … , or a combination of both drugs.The drugs in question, Enzalutamide, is …
-
Astellas Presents Long-Term Data Supporting Sustained Efficacy and Safety of Izervay in Geographic Atrophy
21 Oct 2025 15:21 GMT
Astellas Pharma has announced new findings from … Biopharma and Ophthalmology Development at Astellas. “The ongoing research and data … separate presentation at AAO 2025, Astellas shared insights from a post …
-
Astellas’ Xospata™ (Gilteritinib) now available in Ireland as monotherapy for the treatment of adult patients who have relapsed or refractory acute myeloid leukaemia (AML) with a FLT3 mutation1
21 Oct 2025 09:08 GMT
… subtypes (ITD and TKD).2
Astellas Pharma Co Ltd. Ireland today announced … chemotherapy (9.2%).2
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan … for inquiries or additional information: Astellas Pharma Ireland Communications Valerie Quine valerie …
-
Call over menopause drug for cancer survivors
21 Oct 2025 06:10 GMT
… said.
Drug ';especially valuable' for cancer survivors
Pharmacist Mafalda Mendes … from Allcare Pharmacy in Donnybrook said … and available under the drug schemes, the manufacturer (Astellas) must submit a …
-
Takeda builds in cancer with monster $11.4bn Innovent deal
22 Oct 2025 13:11 GMT
… , and IBI343, an antibody-drug conjugate (ADC) targeting claudin … the willingness of established pharma groups to pay large … colorectal cancer as the drug';s lead indications … therapy targeting claudin 18.2 – Astellas' Vyloy (zolbetuximab) – …
-
This Powerful Drug Combo Cuts Prostate Cancer Deaths by 40%
19 Oct 2025 17:12 GMT
… enzalutamide, an existing cancer drug, with standard hormone therapy. … by the Food and Drug Administration and included in … by Pfizer Inc. and Astellas Pharma Inc., the co-developers … reports being a consultant to Astellas Pharma Inc., AstraZeneca, Bayer, Eli …
-
Drug combo cuts risk of death in advanced prostate cancer by 40%
19 Oct 2025 15:03 GMT
… therapy, which adds a drug called enzalutamide to commonly … by the Food and Drug Administration and listed in … recommendation and solidify this drug combination as the standard … reports being a consultant to Astellas Pharma Inc., AstraZeneca, Bayer, Eli …
-
Meta appoints Juseleen Jalil as HR Director, APAC
22 Oct 2025 11:17 GMT
… 15% over three years.
At Astellas Pharma, she managed HR for Southeast …
-
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients
18 Oct 2025 15:42 GMT
… (MRK), Pfizer (PFE) and Astellas Pharma (ALPMY) are delivering an …
Astellas and Pfizer are partnered on Padcev, an antibody drug … several types of cancer. Antibody drug conjugates, or ADCs, are … side effects associated with the drug class.
In one group, …
-
Astellas-Pfizer’s combination therapy halves risk of death in bladder cancer patients
18 Oct 2025 15:09 GMT
… ) -Pfizer and Japanese firm Astellas’ drug Padcev, combined with Merck’s … with the commonly used cancer drug, cisplatin, and were given …
Merck’s top-selling drug Keytruda helps the body’s … while Padcev, an antibody-drug conjugate, targets specific cancer cells …
About
© 1995-2025